Indian pharma stocks surge to record levels amid broad-based rally

India's pharmaceutical sector extended its upward momentum on Friday, with the Nifty Pharma index reaching record levels as investors showed renewed confidence in the industry. The broad-based rally saw multiple companies posting double-digit percentage gains, signalling strong momentum across the sector.

Sun Pharmaceutical emerged as a standout performer alongside Laurus Labs, Zydus Lifesciences and Sai Life Sciences, each climbing up to 6% during the day's trade. The strong showing across these heavyweight stocks provided significant lift to the overall index.

Beyond the top performers, a wide range of pharmaceutical companies participated in the rally. Mankind Pharma, Ipca Laboratories, Torrent Pharmaceuticals, Divis Laboratories, Cipla and Aurobindo Pharma each posted gains of 2%, reflecting sustained investor interest across the sector's leadership.

The broad participation in Friday's rally suggests renewed optimism among investors regarding the sector's growth prospects and valuations, with both large-cap and mid-cap pharmaceutical companies benefiting from the positive momentum. The record-high level of the Nifty Pharma index underscores the sector's appeal amid India's growing healthcare needs and global pharmaceutical opportunities.